{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:21:10Z","timestamp":1787062870371,"version":"build-2736575974"},"reference-count":20,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"5","license":[{"start":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000},"content-version":"vor","delay-in-days":193,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Long-term use of lithium is a known risk factor for hypercalcemia often due to involvement of the parathyroid gland. Because of this, lithium-induced hypercalcemia typically occurs simultaneously with abnormal parathyroid hormone concentrations. This case report describes a 54-year-old white male who has received lithium therapy intermittently for more than 10 years. During admission to an acute inpatient psychiatric unit, the patient experienced hypercalcemia with normal parathyroid hormone concentrations and no other discernible cause. Based on the Naranjo algorithm, lithium was determined to be the probable cause of hypercalcemia. Current literature suggests that lithium-induced hypercalcemia occurs secondary to hyperparathyroidism; however, this case may provide evidence of another, unidentified cause.<\/jats:p>","DOI":"10.9740\/mhc.2019.09.318","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T16:12:51Z","timestamp":1567613571000},"page":"318-321","source":"Crossref","is-referenced-by-count":10,"title":["Lithium-induced hypercalcemia with normal parathyroid hormone: A case report"],"prefix":"10.9740","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-5452","authenticated-orcid":false,"given":"Charles","family":"Dorflinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9404-1713","authenticated-orcid":false,"given":"Matthew","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4719","reference":[{"issue":"6","key":"2020060307344437300_i2168-9709-9-5-318-b01","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/j.1399-5618.2009.00737.x","article-title":"The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments","volume":"11","author":"Ng","year":"2009","journal-title":"Bipolar Disord"},{"issue":"2","key":"2020060307344437300_i2168-9709-9-5-318-b02","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord"},{"issue":"11","key":"2020060307344437300_i2168-9709-9-5-318-b03","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1007\/s00268-009-9942-4","article-title":"Lithium therapy and hyperparathyroidism: an evidence-based assessment","volume":"33","author":"Saunders","year":"2009","journal-title":"World J Surg"},{"key":"2020060307344437300_i2168-9709-9-5-318-b04","unstructured":"Siemens Healthcare Diagnostics Inc. Dimension Vista\u00ae System: Flex\u00ae reagent cartridge information. Tarrytown (NY): Siemens Healthcare Diagnostics; 2017."},{"issue":"3","key":"2020060307344437300_i2168-9709-9-5-318-b05","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.emc.2018.04.008","article-title":"Rapid fire: hypercalcemia","volume":"36","author":"Carrick","year":"2018","journal-title":"Emerg Med Clin North Am"},{"key":"2020060307344437300_i2168-9709-9-5-318-b06","article-title":"Hypercalcemia [Internet]","author":"Naganathan","year":"2018","journal-title":"StatPearls"},{"key":"2020060307344437300_i2168-9709-9-5-318-b07","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2194-7511-1-18","article-title":"Hypercalcemia in patients with bipolar disorder treated with lithium: a cross-sectional study","volume":"1","author":"Twigt","year":"2013","journal-title":"Int J Bipolar Disord"},{"key":"2020060307344437300_i2168-9709-9-5-318-b08","article-title":"Physiology, parathyroid hormone (PTH) [Internet]","author":"Khan","year":"2018","journal-title":"StatPearls"},{"issue":"6","key":"2020060307344437300_i2168-9709-9-5-318-b09","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ki.1985.220","article-title":"Effect of inorganic phosphate on serum ionized calcium concentration in vitro: a reassessment of the \u201ctrade-off hypothesis\u201d","volume":"28","author":"Adler","year":"1985","journal-title":"Kidney Int"},{"issue":"33","key":"2020060307344437300_i2168-9709-9-5-318-b10","doi-asserted-by":"publisher","first-page":"30337","DOI":"10.1074\/jbc.M201804200","article-title":"Human calcium-sensing receptor gene","volume":"277","author":"Canaff","year":"2002","journal-title":"J Biol Chem"},{"issue":"4","key":"2020060307344437300_i2168-9709-9-5-318-b11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00268-002-6824-4","article-title":"Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy","volume":"27","author":"Awad","year":"2003","journal-title":"World J Surg"},{"issue":"3","key":"2020060307344437300_i2168-9709-9-5-318-b12","doi-asserted-by":"publisher","first-page":"F485","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"9","key":"2020060307344437300_i2168-9709-9-5-318-b13","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1210\/jc.82.9.2844","article-title":"Fuleihan G el-H. Alterations in parathyroid dynamics in lithium-treated subjects","volume":"82","author":"Haden","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020060307344437300_i2168-9709-9-5-318-b14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00268-017-4328-5","article-title":"Lithium-associated hypercalcemia: pathophysiology, prevalence, management","volume":"42","author":"Meehan","year":"2018","journal-title":"World J Surg"},{"issue":"9","key":"2020060307344437300_i2168-9709-9-5-318-b15","first-page":"1959","article-title":"A practical approach to hypercalcemia","volume":"67","author":"Carroll","year":"2003","journal-title":"Am Fam Physician"},{"issue":"2","key":"2020060307344437300_i2168-9709-9-5-318-b16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4158\/EP.2.2.103","article-title":"Lithium therapy and disorders of the parathyroid glands","volume":"2","author":"McHenry","year":"1996","journal-title":"Endocr Pract"},{"issue":"11","key":"2020060307344437300_i2168-9709-9-5-318-b17","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1210\/jc.2018-01225","article-title":"Primary hyperparathyroidism","volume":"103","author":"Bilezikian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2020060307344437300_i2168-9709-9-5-318-b18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2020060307344437300_i2168-9709-9-5-318-b19","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/jc.2008-1760","article-title":"Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Silverberg","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020060307344437300_i2168-9709-9-5-318-b20","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1007\/s00268-009-9942-4","article-title":"Lithium therapy and hyperparathyroidism: an evidence-based assessment","volume":"33","author":"Saunders","year":"2009","journal-title":"World J Surg"}],"container-title":["Mental Health Clinician"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/9\/5\/318\/2427722\/mhc_2019_09_318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/mhc\/article-pdf\/9\/5\/318\/2427722\/mhc_2019_09_318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T11:26:03Z","timestamp":1731669963000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/9\/5\/article-p318.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.9740\/mhc.2019.09.318","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}